| 영문 | rheumatoid factor | 한글 | 류마티스 인자 |
|---|---|---|---|
| 설명 | IgG의 Fc부위에 있는 항원결정인자에 대한 항체로서 전형적인 또는 확실한 류마티스관절염(rheumatoid arthritis) 환자의 80%에서 발견된다. 류마티스 인자는 IgM, IgG, IgA중 하나가 될 수 있으나 주로 IgM이다. 소아류마티스관절염(juvenile rheumatoid arthritis: 소아기에 발생하는 류마티스관절염)을 비롯한, 다른 결합조직병이나 감염병에도 나타날 수 있다 |
||
| 영문 | growth factor | 한글 | 성장인자 |
|---|---|---|---|
| 설명 | 세포의 분화 및 성장에 관여하는 단백질. 성장인자는 정상 세포주기에 필수적이기 때문에 동물의 생명에 중대한 요소가 된다. 무엇보다도 성장인자는 태아의 발육을 조정하고 조직의 유지 및 보수에 중대한 역할을 하며, 혈구의 생성을 자극한다. 또한 암의 진행과정에도 관여한다. |
||
| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
|---|---|
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| CE | Competitive exclusion |
|---|---|
| HVE | Hepatic Vascular Exclusion |
| HPSEC | High Performance Size Exclusion Chromatography |
| SEC | Size Exclusion Chromatography |
| SE-HPLC | Size exclusion high performance liquid chromatography |
IGF-II : insulin like growth factor-II의 약자. 많은 장기와 조직에 작용하여 단백 합성과 DNA, RNA의 합성을 증가시켜 세포의 수와 양을 증가
| confounding factor | <epidemiology> Factors that can cause or prevent the outcome of interest, are not intermediate variables, and are not associated with the factor(s) under investigation. They give rise to situations in which the effects of two processes are not separated, or the contribution of causal factors cannot be separated, or the measure of the effect of exposure or risk is distorted because of its association with other factors influencing the outcome of the study. (03 Jul 1999) |
|---|---|
| confounding | 1. A situation in which the effects of two or more processes are not separated; the distortion of the apparent effect of an exposure on risk, brought about by the association with other factors that can influence the outcome. 2. A relationship between the effects of two or more causal factors observed in a set of data, such that it is not logically possible to separate the contribution of any single causal factor to the observed effects. (05 Mar 2000) |
| allelic exclusion | <cell biology, genetics> The process whereby one or more loci on one of the chromosome sets in a diploid cell is inactivated (or destroyed) so that the locus or loci is (are) not expressed in that cell or a clone founded by it. For example in mammals one of the X chromosome pairs of females is inactivated early in development (see Lyon hypothesis) so that individual cells express only one allelic form of the product of that locus. Since the choice of chromosome to be inactivated is random, different cells express one or other of the X chromosome products resulting in mosaicism. The process is also known to occur in immunoglobulin genes so that a clone expresses only one of the two possible allelic forms of immunoglobulin. (19 Dec 1998) |
| gel exclusion chromatography | <investigation> A lab technique, a type of column chromatography, used to separate the components of a mixture by molecular size and to collect the molecules which are larger than a certain size. It is similar to gel filtration, small molecules are slowed or trapped by the pores in the gel beads filling the column, while large molecules, too large to fit into the pores, slide past the beads and get to the bottom of the column first. at this point, the large molecules are collected. Gel exclusion refers to the maximum size of molecule which will fit into the gel bead pores, and this lab technique is used to collect the molecules in the mixture which are larger than, or excluded from, the pores. (09 Oct 1997) |
| Pauli's exclusion principle | The theory limiting the number of electrons in the orbit or shell of an atom; that it is not possible for any two electrons to have all four quantum numbers identical. (05 Mar 2000) |
| Devine exclusion | Exclusion of the lower part of the stomach, followed by gastrojejunostomy, for treatment of duodenal ulcer. (05 Mar 2000) |
| diagnosis by exclusion | A diagnosis made by excluding those diseases to which only some of the patient's symptoms might belong, leaving one disease as the most likely diagnosis, although no definitive tests or findings establish that diagnosis. (05 Mar 2000) |
| dye exclusion test | A test to determine cell viability in which a dilute solution of certain dyes (e.g., trypan blue, eosin Y, nigrosin, Alcian blue) is mixed with a suspension of live cells; cells that exclude dye are considered to be alive while cells that stain are considered dead; it is not always an accurate test because it indicates only the structural integrity of the cell membrane. (05 Mar 2000) |
| exclusion | 1. The act of excluding, or of shutting out, whether by thrusting out or by preventing admission; a debarring; rejection; prohibition; the state of being excluded. "His sad exclusion from the doors of bliss." (Milton) "The exclusion of the duke from the crown of England and Ireland." (Hume) 2. <physiology> The act of expelling or ejecting a foetus or an egg from the womb. 3. Thing emitted. Origin: L. Exclusio: cf. F. Exclusion. See Exclude. Source: Websters Dictionary (01 Mar 1998) |
| exclusion of pupil | The condition resulting from posterior annular synechia, in which the iris is bound down throughout the entire pupillary margin, but the pupil is not occluded. Synonym: exclusion of pupil. (05 Mar 2000) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| adrenal weight factor | A postulated substance of adenohypophysial origin responsible for maintenance of the weight of the adrenal cortex. (05 Mar 2000) |
| adrenocorticotropic releasing factor | Hormone produced by hypothalamus that causes pituitary to secrete adrenocorticotropic hormone. (05 Mar 2000) |
| a-factor | <molecular biology> A protein which is found in the bacterial genus Streptomyces that helps start the production of streptomycin and the process of morphological differentiation. It is used in biotechnology to induce these functions in mutant strains of Streptomyces that cannot produce it themselves. (09 Feb 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|